METHODS 114
A protocol detailing the methodology was registered (PROSPERO (CRD42015023903)) and published 115 [18] . A summary of the methods is described here. 116 117 Bibliographic databases were searched to 3 rd August 2015 (MEDLINE, PubMed, Embase, CINAHL, 118
Cochrane Central Register of Controlled Trials (CENTRAL) and Scopus) using a combination of index 119 and text words relating to the population (burns patients) and quantitative burn wound 120 microbiology. There was no restriction by language, study design or outcome. A sample search 121 strategy for MEDLINE is shown (Supplementary Figure S1 ). ZETOC (British library) and the Science 122
Citation Index (Web of Science) were searched for conference proceedings. Abstracts from national 123 and international burns and microbiology conferences were searched from 2012 onwards. Clinical 124 trial registries were searched for ongoing trials and relevant articles were citation checked. 125
As the review encompassed a range of study designs with different study aims, it was necessary to 140 include risk of bias criteria from different tools. Risk of bias assessment therefore included, where 141 relevant for individual studies, elements from the 'COnsensus-based Standards for the selection of 142 health Measurement Instruments' (COSMIN) tool [19] (e.g. were any samples taken in duplicate or 143 was there >1 independent assessor?); the Quality Assessment of Diagnostic Accuracy Studies (revised 144 tool) (QUADAS-2) checklist [20] (e.g. were samples for both tests collected at the same time?); and 145 the Quality in Prognosis Studies (QUIPS) tool [21] (e.g. are important potential confounding factors 146 appropriately accounted for?). Items from the latter tool were important for assessing the 147 prognostic validity of a study using bacterial count as a prognostic marker of future clinical outcomes 148 such as sepsis. Items from the former tools related to the reliability and repeatability of different 149 methods and any agreement between them. Full details of the quality assessment can be found in 150
Supplementary Figure S2 . 151 152 Synthesis was narrative with main findings (and any statistical significance) tabulated. Studies were 153 grouped by clinical question, with some studies providing evidence for more than one question. 154
Heterogeneity in population, sampling and culturing methods and reported outcome metrics 155 precluded quantitative pooling, however similarities and differences between study findings were 156 described. Where findings were dichotomised according to a threshold, this was considered when 157 comparing studies. All findings were considered in the context of any risk of bias concerns, and gaps 158 in the evidence highlighted where appropriate. 159 160 Formal assessment of publication bias was not possible. Preferred Reporting Items for Systematic 161
Reviews and Meta-Analyses (PRISMA) reporting guidelines [22] were adhered to, and the study 162 selection process documented using a PRISMA flow diagram. 163 164 165 4 RESULTS 166
Overall summary 167
Twenty-six studies were included (see Figure 1 for selection procedure). The studies were published 168 between 1974 and 2013, but mostly conducted in the 1970s and 1980s. Twelve were laboratory 169 comparisons of bacterial counts obtained from different sampling methods, and 14 incorporated 170 both laboratory aspects and clinical outcomes. 171 172
4.2
Intra-and inter-observer repeatability of the different methods of obtaining bacterial 173 counts 174
Only three small studies (46 patients in total) reported on duplicate sampling using duplicate swab 175 collection [23], duplicate biopsies [24] and both duplicate swabs and biopsies [25] . All duplicate 176 samples were processed using the same methods, therefore allowing assessment of reliability. No 177 studies were identified that reported on inter-observer reliability. Details of sampling methods, main 178 findings and methodological strengths and weaknesses are detailed in Table 1 . 179 Levine et al [23] collected duplicate swabs to assess the variation in quantitative cultures from 180 widely spaced areas on wounds of uniform clinical appearance. Twenty four patients, with large 181 areas of exposed granulation tissue, were included and had swabs collected from four separate 182 areas per wound. Assessment of variability showed that 95% of the counts obtained from the four 183 swabs were ±1.7 logs from the mean count per sample set (95% confidence interval (CI)). Mean 184 counts are not reported. It is also unclear whether the samples with no bacterial growth were 185 included or excluded from the analysis as per Steer et al [25] . 186 Volenec et al [24] collected 36 punch biopsies from four burns patients (27 pairs analysed), and 187 assessed the variability in counts per gram between the duplicate samples. The 95% CI was ±1.31 188 log 10 counts/g across all the samples. The results from these two studies suggest that a single 189 sample may be able to provide a reliable approximation of the number of organisms present, 190 without the need to collect duplicate samples. 191 Steer et al [25] , collected duplicate biopsies and swabs (two of each per patient) from 18 patients. 192 The authors found that there was a significant correlation between the log total bacterial counts 193 obtained from two simultaneous biopsies (p<0.002), and from two swabs (p<0.001) collected from 194 the same patient at the same time only if samples without growth were included. When samples 195 without growth were excluded from the analysis (since by being negative, they are automatically 196 concordant), the correlation between simultaneous biopsies was no longer significant, and only 29% 197 of biopsies and 50% of swab counts agreed within the same log unit. The 95% CI ranges for biopsies 198 and swabs respectively were ±5.4 log 10 counts/g, and ±3.6 log 10 counts/cm 2 . This wide range may be 199 due to the variation in sampling area for swabs. The authors conclude that single samples are not 200 sufficient for measuring bacterial counts, and that one sample type cannot be used to predict the 201 counts obtained from another sample type. 202
Comparisons across the three studies are difficult owing to the heterogeneity in terms of the 203 samples collected (all studies involve different sampling methods and sites), and the populations 204 studied. Several methodological weaknesses were also noted, especially the inadequate detail 205 regarding how samples were processed. Whilst all studies provide measures of variation, there is no 206 indication of reference values or guidance on clinical interpretation. Overall, there is insufficient 207 evidence to draw conclusions on the reliability of the methods described. 208 209
Agreement between different methods 210
Twenty two studies [5,11,12,23,25-42] compared two or more methods of quantification, including 211 charcoal swabs, biopsies (of a variety of types), and blood cultures. The methods for processing the 212 samples (where stated) tended to be broadly similar, involving collection and plating onto solid agar 213 (±quantitative counts) for the swabs, and homogenisation, serial dilution and plating (culture) for 214 the biopsies, although there was a lack of reporting on the method of biopsy collection, or type of 215 biopsy for three studies [34, 38, 39] . Details of all the studies are shown in Tables 2 (A-D), and are 216 described in the following text. 217
Agreement in bacterial counts with different sections from the same biopsy/biopsy site 218
Four studies investigated bacterial counts obtained from different sections of the same biopsy or 219 biopsy sites [34, [38] [39] [40] , however there are several methodological weaknesses; only one study [40] 220 provided detail on biopsy collection and processing method, and all provide only minimal detail on 221 the patient population (Table 2A) [40] were analysed separately according to whether the same bacterial isolate was 230 recovered from both split biopsy samples (paired), or whether the samples were discordant 231 (unpaired). For 43% of the paired biopsies, the quantitative results were within the same log 232 increment. Combining the paired and unpaired samples, 21% of the quantitative results were within 233 the same log increments, 19% differed by ±1 log increment, and 60% differed by ±2 log increments 234 or more. Although there are no reference ranges to guide interpretation, it appears that there is vast 235 variation in different segments from the same biopsy specimen. 236
Agreement in bacterial counts between different processes used on single biopsies 237
Five studies compare quantitative counts from single biopsies processed using quantitative culture 238 compared to a range of other methods (Table 2B) provided on the processing of the sample for two studies [26, 27] . The studies also vary in the skin 243 preparation before biopsy collection, with three removing topical agents prior to sample collection 244 [26, 27, 41] , and no details on skin preparation for the other studies. This lack of detail makes it 245 difficult to compare the robustness of study methodologies. 246
Three studies reported concordance between methods: this ranged from 96% for quantitative versus 247 semi-quantitative [26], to 100% for quantitative versus acridine orange microscopy [27] , but this 248 latter result is misleading as this only relates to the culture positive samples, and 35% of the culture 249 negative samples were positive on microscopy. Woolfrey et al [28] report a moderate positive 250 association (correlation coefficient of 0.5) between quantitative and Gram stains, and using 251 regression line analysis, indicate that the presence of 1.1x10 5 stained microorganisms per slide 252 preparation corresponds to the recovery of 10 6 cfu/gram on quantitative culture. Only a small 253 proportion of samples (17%) were analysed in Pruitt & Foley [5] , and no concordance data reported. 254
Williams et al [41] also provide no summary concordance data for the bacterial counts obtained 255 from the biopsies versus absorbent discs, instead reporting the correlation coefficients between the 256 methods in terms of the frequency of isolation of the four most common organisms. Overall, the 257 paucity of studies, and heterogeneity between study methodologies, precludes any conclusions 258 relating to the best method for processing biopsies for obtaining reliable bacterial counts. 259 260
Comparison of bacterial counts obtained from swabs versus biopsies 261
Seven studies compared bacterial counts obtained from swabs versus biopsies (Table 2C) The studies also differed according to whether or not quantitative counts were performed for both 267 sample types. Three studies report their main findings as 'concordance between sampling methods 268 in terms of positive and negative results'; in these studies quantitative counts were not performed 269 on the swabs [29,30], or were not performed/reported for either of the sample types [31] . No 270 quantitative results were reported, and the studies mention only that 'similar' bacteria were present 271 between the two sample types. 
Comparison of bacterial counts obtained from swabs versus biopsies versus blood cultures 289
Six studies report the bacterial counts obtained from different samples collected from the same 290 patient (Table 2D ). There is a lack of detail on sample collection for swabs and/or blood cultures for 291 five studies [11, [35] [36] [37] 42] , and the type of biopsy sample collected is not detailed in Bahar et al [42] 292 (although the weight of the biopsy is stated). 293
294
There is heterogeneity in both the types of biopsy that were collected (Loebl et al [10] method, or 295 dermal punches), and the preparation of the skin prior to sampling. Only two of the six studies 296
[36,37] mention that the sampling was performed aseptically. Without aseptic collection, biopsies 297 may be positive because of translocation of the bacteria into the sample during sample collection 298 rather than invasion of bacteria. This also applies to the collection of blood cultures and is a 299 considerable methodological flaw of these studies. between swabs and biopsies, Uppal et al [12] , where the concordance between the swabs and 318 biopsies was 95%, and Steer et al [11] where there was no significant difference in counts between 319 the different sample types. These studies however were methodologically weaker owing to the lack 320 of reporting or performing of skin asepsis. 321 322
Comparison of bacterial counts obtained from biopsies versus blood cultures 323
One study [43] (not tabulated) compared bacterial counts from biopsies versus blood cultures. 324
Samples were collected (biopsies as per Loebl et al [10] ) from 38 patients with >20% TBSA on the day 325 of admission to the hospital, and every third day thereafter. They were processed to obtain 326 quantitative counts, and positives defined by counts ≥10 4 orgs/g. In terms of concordance between 327 the samples, 92% of the biopsies were positive, but only 29% of these positives matched a 328 simultaneously positive blood culture. 329 counting methods on the decision for antimicrobial therapy, but did not relate this to outcomes such 335 as sepsis or mortality. 336 337
Studies reporting sepsis 338
Sepsis was assessed in nine [5, 10, 11, 29, 34, 35, 37, 43, 44] of 13 studies. Definitions of sepsis (where 339 described) varied across the studies (Table 3) Medicine (SCCM) [45, 46] , although it must be acknowledged that the majority of the studies predate 344 these guidelines. 345
Additionally, positive culture thresholds were not defined for seven studies [5, 11, 30, 31, 34, 42, 44] , 346 and for the remainder, the threshold ranged from 10 4 to 10 5 bacteria/gram (Table 4 ). Patient 347 populations varied between the studies in terms of the %TBSA. 348 349
Utility of different sample types and quantitative microbiology for predicting sepsis 350
Thirteen clinical studies investigated the ability of swabs, biopsies and/or blood cultures, and 351 quantitative microbiology to predict a range of clinical outcomes ( All studies found that biopsies were more sensitive than swabs and/or blood cultures for diagnosing 357 infection and predicting the likelihood of sepsis. Sjoberg et al [37] showed that the development of 358 sepsis was better correlated to quantitative burn tissue biopsy cultures than surface swab cultures 359 (but commented that the time needed for processing limits its predictive and therapeutic value), and 360
Tahlan et al [29] found that surface swabs in general fail to accurately predict progressive bacterial 361 colonisation or incipient burn wound sepsis. Additionally, Loebl et al [10] cultures. They also found a false positive rate of 10% (i.e. positive blood culture, but no simultaneous 381 clinical signs of sepsis). This is higher than previously reported rates of 0.6-6.0% [47], but could be 382 explained by a commensal being isolated from the blood, and delayed onset of sepsis in the patients 383 the samples were collected from. 384
In contrast, two studies [29, 36] found positive blood cultures to be associated with poor prognosis in 385 burns patients (especially if they are positive within 24 hours of burn), and in many cases predicted 386 impending mortality. The data regarding the sensitivity and specificity of blood cultures for the 387 diagnosis of sepsis from these studies have to be interpreted with caution. Many of these studies 388 only required one positive blood culture for their analyses and as discussed previously their 389 definitions of clinical sepsis were deeply flawed. The ABA criteria [45, 46] define blood stream 390 infection as a recognised pathogen cultured from two or more blood cultures, or one positive blood 391 culture in the presence of sepsis. It is also important to consider the timing of blood culture 392 collection. For example, blood cultures collected from pyrexial patients/episodes are more likely to 393 be microbiologically positive than those collected from non-pyrexial patients/episodes. 394
In terms of quality assessment, all of the above studies have methodological limitations which affect 395 the validity of the data. These include failure to define thresholds for positive cultures [ mortality by looking at the association between counts from swabs and biopsies and mortality for 408 75 patients. There was no statistically significant difference in counts between those who died and 409 those who survived; 59 patients died, of whom 48 had bacterial counts greater than 1x10 5 cfus (units 410 not stated), compared to 16/16 patients who survived but still had this high level of bacterial 411 bioburden from the biopsy samples (Table 4 ). This was consistent with the findings from Pruitt & 412 Foley [5] who performed quantitative counts on biopsies from 23 patients. There was no statistically 413 significant difference between the groups: 15/20 (75%) patients with >10 5 orgs/gram died (the 414 remaining five survived), whereas 1/3 pts with counts <10 5 orgs/g died (the remaining two survived). 415
Steer et al [11] analysed 69 swab and biopsy pairs from patients with 1-65% TBSA, and also 416 concluded that there was no statistically significant difference in total bacterial counts 417 (biopsy/surface) between patients judged as a clinical success or failure, and no variation in counts 418 according to whether patients underwent excision and grafting or change of dressings. However, the 419 authors also found a significant negative correlation between quantitative counts from swabs and 420 %TBSA (p=0.006) (i.e as TBSA increases, the counts decrease). This is in stark contrast to what would 421 be expected, and what is observed in clinical practice, and therefore suggests some error or serious 422 methodological flaws in the study. 423
Two studies [29, 37] found that there was a difference in terms of bacterial counts in those with 424 sepsis compared to those without, and three studies [5,30,36] concluded that high bacterial load in 425 biopsies increased the risk of sepsis and mortality. Sjoberg et al [37] collected swabs, biopsies, and 426 blood cultures from 50 burns patients, whilst monitoring them (every 4 hours) for signs of sepsis. 427
The patients were then split into 'septic' (n=21) vs 'non septic' (n=29). Overall, bacterial load (from 428 biopsies) was significantly higher (p<0.05) in patients with signs of septicaemia compared to those 429 without ( reported that patients with burn wounds which showed >10 5 organisms/gram in biopsy tissue 436 seemed to be 'more likely' to die even with additional measures (e.g. aggressive wound care, 437 assisted ventilation etc). This finding is however based on only 10/21 patients, and a lack of 438 information on the remaining patients means the findings should be viewed cautiously. 439
The majority of studies had some methodological limitations, particularly in terms of reporting 440 outcomes for all patients (not just those with high counts) and there does not appear to be any 441 correlation between the findings and how robust the studies were. 442 This systematic review was undertaken to clarify the evidence base around the use of quantitative 465 microbiology (specifically from biopsy samples) for the management of burns patients. This is the 466 first systematic review in this area and was warranted owing to the conflicting and varied reports of 467 the clinical utility of quantitative counts in the literature. A sensitive search strategy meant that is it 468 unlikely that any studies would have been missed, and detailed risk of bias assessment of included 469 studies meant that any findings have been set in the context of the methodological quality of the 470 primary studies. 471
Twenty six studies were included, of which twelve investigated clinical outcomes. There was 472 substantial heterogeneity in terms of patient characteristics (%TBSA, type of burn injury, the time of 473 presentation post burn), sample collection and processing (e.g. the type of biopsy collected, and 474 whether skin was aseptically cleaned beforehand), the method for performing the counts, the 475 analysis, and how the clinical outcomes were defined. This precluded any quantitative synthesis (e.g. 476 meta-analysis), and hence findings are described narratively, sub-grouped by clinical question. 477
A key finding from this systematic review is that there is not a gold standard nor universally accepted 478 method for monitoring a burn wound for bacterial colonisation and infection. Studies using any 479 method of quantitative microbiology from biopsy samples were eligible for inclusion into the review 480 resulting in a range of different types of biopsy collected, whilst in six studies [5, 23, 30, 34, 38, 39] the 481 authors failed to provide any information regarding the biopsy type. Furthermore, the comparator 482 samples such as swabs, surface plates or blood cultures also varied between studies in how they 483 were collected (e.g. the area of the skin swabbed), and how they were processed. The different 484 methods of processing may be the reason why the critical bacterial concentrations necessary for 485 burn wound sepsis vary so widely between studies. Freshwater et al [44] for example have 486 theorised that the method of tissue homogenisation significantly impacts the critical number due to 487 less efficient means of homogenisation yielding less recoverable bacteria from tissue samples. It 488 remains unclear what the best method is to obtain bacterial counts from a burn wound. 489
In addition to variation in sample types, for some studies, the samples being investigated were not 490 collected at the same time per patient, or there was no information provided on when (post-burn 491 injury) the samples were collected. This is of utmost importance when the bacterial counts are being 492 compared from different sample types and across different studies. 493
Limited evidence does suggest that it is not sufficient to base clinical decisions on a single sample, 494 and that swabs (although a convenient sample type) generally only detect the surface flora, and 495 therefore do not reflect the invasion of the wound and potential progression to sepsis. In terms of 496 bacterial density and wound invasion, Winkler et al [32] hypothesised that the discrepancy between 497 surface swab and biopsy findings were linked to bacterial density (i.e. that when bacterial counts are 498 <10 5 organisms/g, deep invasion of wounds is not expected and biopsy results then correlate with 499 surface techniques). However, high bacterial density does not always lead to invasion, as reported 500
by McManus et al [39] . It is likely that the depth of invasion (especially involvement of healthy tissue 501 and vascular involvement) in combination with bacterial density on biopsy will be a more accurate 502 predictor of sepsis and mortality compared to just bacterial density alone. 503 Furthermore, it is clear that there are insufficient robust studies to fully investigate the utility of 504 blood cultures; only one study [43] specifically investigated this, but was methodologically weak 505 owing to biased selection of patients ( those 'believed to be a high risk of septic complications'), lack 506 of statistical testing, and incomplete reporting of results. All other studies investigating blood 507 cultures differed in time of sample collection, with some collected when a pyrexial spike was present 508 in the patient [29], at a pre-determined time not associated with clinical condition of the patient 509
[11,35-37], or at an unknown time (detail not provided) [5, 42, 43] . 510
In terms of clinical outcomes, eight of nine studies (investigating sepsis) seem to suggest that 511 biopsies performed better than swabs (or other comparators) in terms of correlation with sepsis. 512
However the utility of quantitative analysis of biopsies is still not clear as three of 13 clinical studies 513 [11, 42, 44] have also reported no correlation of biopsy results with clinical outcomes. These 514 conflicting findings may be a result of differences in methodological quality between studies, or 515 other sources of heterogeneity (e.g. population characteristics). Methodological flaws (or omissions 516 in reporting) in the clinical studies include: the time of sample (biopsy) collection not being stated 517 (bacterial density and antibiotic resistance has been shown to increase with longer time from burn 518 [35,37,48,49]), the lack of a common definition of sepsis, and ambiguity surrounding when mortality 519 is attributed to infection. For infection-attributed deaths, there is no clear definition or explanation 520 on how this was decided (e.g. in some cases, patients may have died of other non-infection related 521 cause). All of these factors may affect the robustness of the clinical findings, and these should 522 therefore be interpreted very cautiously. Furthermore, none of the studies have adjusted their 523 findings for potential confounding factors (i.e. other factors that might predispose a patient to 524 adverse clinical outcomes). These include age, burn depth and severity, and inhalation injury, and 525 may all lead to an inaccurate attribution of adverse clinical outcomes to high bacterial counts. 526
It may also be that sepsis is not a suitable clinical outcome to use for burns patients. It has been 527 recognised for many years now that the SIRS and sepsis criteria do not apply well to burns patients 528 due to their elevated systemic inflammatory response (e.g. a baseline temperature of 38.5ºC, and 529 persistent tachycardia and tachypnoea). Many burns patients would thus trigger the criteria even 530 when no infection is present thus making it difficult to detect true sepsis. Recognising this flaw, the 531 American Burn Association (ABA) has published improved standardised definitions for sepsis and 532 infection-related diagnoses for the burn population in 2007 [46] . Higher thresholds and some new 533 criteria were introduced e.g. using temperature 39°C (versus ACCP and SCCM criteria of 38°C), 534 tachycardia 110bpm (versus 90bpm), thrombocytopenia (3 days after initial resuscitation) and 535 hyperglycaemia (>0.200mg/dl), instead of leucocytosis, as markers of infection. It is thus likely that 536 these historical papers (by using simple definitions of sepsis) have overestimated the incidence of 537 true infection in their studied cohort. 538
A key question to address surrounds the relevance of bacterial counts to clinical outcomes. Out of 539 the 13 clinical studies, ten [5,10,29-31,34-37,43] found that high bacterial counts were associated 540 with a poorer prognosis, although the link between high bacterial density and adverse clinical 541 outcomes is far from clear, as three studies [11, 42, 44] found no correlation between clinical 542 outcomes and high bacterial load or density. 543
This discrepancy in findings may be due to the fact that the relationship between microbial 544 colonisation and clinical outcomes is much more complicated and cannot be determined merely by additionally have a different propensity for invasiveness. Microbes cause skin graft failure by the 553 production of plasmin and proteolytic enzymes that dissolve the fibrin scaffold that allows skin grafts 554 to adhere to the wound bed and it is known that different bacteria have varying levels of efficiency 555 in producing these enzymes [51] . 556
It appears from the findings that in addition to bacterial density, the type of bacteria, depth of 557 invasion (especially the invasion into healthy non-burned tissue,) and antibiotic resistance all need to 558 be taken into account when analysing these biopsies and correlating them to clinical outcomes. Limited evidence suggests that in order to obtain the most reliable bacterial counts (i) more than 574 one sample is required, ideally from multiple anatomical areas [44] (due to the variability of bacterial 575 counts from samples even in different segments of the same biopsy specimen); (ii) in terms of 576 sensitivity, biopsies generally outperform swabs in diagnosis or predicting sepsis but have limited 577 applicability due to the longer processing time; (iii) high bacterial loads may predict worse clinical 578 outcomes (than low bacterial loads) but information on counts need to be combined with other 579 factors such as depth of invasion and invasion into healthy tissue to be relevant; and (iv) both 580 quantitative and semi-quantitative culture reports need to be interpreted with caution and not in 581 isolation but alongside clinical findings. 582
There is a clear need for a robust study to be performed to fully address the question of whether 583 quantitative microbiology (namely biopsies) are of clinical utility for the management of burns 584 patients, and furthermore whether there is indeed a direct link between the bioburden of a wound 585 and the risk of microbial invasion. This systematic review has shown that there is currently no good 586 evidence to prompt a change in practice, since, in additional to the methodological flaws and 587 shortcomings, 77% of the included studies have been performed more than two decades ago, and in 588 that period burn wound care has undergone significant changes. These include new treatments 589 These changes may mean that the findings from the older studies (where a limited selection of 598 bacterial isolation media were used) may no longer be applicable to current clinical practice, and 599 thus newer studies need to be performed. 600
Several areas however need to be addressed before such studies are performed. Firstly, faster and 601 more reproducible techniques for the identification and quantification of bacteria need to be in 602 place. In the absence of a gold standard method, studies need to be undertaken to check and 603 improve the reliability/reproducibility of the chosen wound sampling method and as mentioned 604 previously, multiple site sampling needs to be performed instead of single site sampling. Secondly, 605 even if quantification is successful, it would only prove useful clinically if the results are available 606 rapidly (in hours rather than days), and thus rapid techniques need to be tested or devised. In terms 607 of clinical outcomes, a standardised minimum (or core) set of clinical outcomes needs to be devised 608 and agreed upon by all stakeholders in advance, in order to allow comparison of trials across 609 different centres. 610
It is hoped that once a carefully designed multi-centre study has been undertaken that the evidence 611 base on the utility and reliability of quantitative microbiology for diagnosing or predicting clinical 612 outcomes in burns patients can be clarified. Four swabs were collected from 41 wounds and the mean log bacterial counts and standard error calculated per wound. The mean standard deviation was ±0.85 logs, and 95% of all results were ±1.7 logs from the mean per sample set (95% CI).
(-) Inadequate detail in terms of the sampling and the standard treatments. (-) Inadequate detail in terms of the processing of the swabs and how the quantitation was performed.
Volenec et al [24]
Four burn patients (unknown aetiology, 40-67% TBSA).
Wounds washed free of topical antimicrobials before sampling (but no further details) 4 mm punch biopsy (exact method not stated) were collected on alternate days.
Patients were sampled on a number of occasions (exact details not given) n/a 36 paired samples collected and 27 analysed (8 pairs excluded as counts too low, and one excluded as counts too high).
The counts per gram (in log) were compared between the samples in terms of range and standard deviation (SD). The mean range difference was low at 0.67 log, and mean SD was 0.64 log. 95% of all results were ±1.31 logs from the mean. Results reported in terms of counts per gram (biopsies), and per cm 2 (swabs). There was a significant correlation between the log total bacterial counts obtained from two simultaneous biopsies (p<0.02), and two swabs (p<0.001).
(+) Duplicate samples were collected from the same patient at the same time. [10] Single biopsy split in half transversely. Both segments processed by quantitative culture Compared the counts between the two segments. For the paired isolates, 43% of the counts were within the same log increment, 29% differed by ±1 log increment, and 27% differed by ±2 log increments.
(+) Full details given for biopsy processing (+) Skin surface cleansed with an alcohol-soaked sponge before sampling (-) Patient population not stated. Single biopsy compared to an absorbent disc (of the same size) collected from the same area.
Correlation coefficients between methods in terms of bacteria isolated for the four most common organisms. Ranges from 0.66 (Enterococci) to 0.86 (Pseudomonas aeruginosa). No summary concordance data given for the bacterial counts.
(+) Sample processing details provided (+) Counts performed on both sample types (-) Skin prep performed before sampling (to remove topical agents) but no skin asepsis. Poor and nonsignificant correlation between the bacterial counts from biopsies and swabs. To evaluate whether QM is useful in predicting the possibility of septicaemia Sepsis, mortality Based on the following parameters (but did not state how many were required to be present for diagnosis): body temp (<36⁰C or >39 ⁰C), blood pressure (<90mm Hg or a reduction of 40mm HG or more), pulse rate (above 90 BPM), altered mental status. Steer et al [11] To examine the relationship between clinical outcome and bacterial densities Use of antimicrobials within 72 hours of operation or dressing Appearance of fever (>38⁰C), rigors, hypotension, or graft loss (>5%) change, sepsis, and graft loss. Tahlan et al [29] No clinical aims stated Sepsis, mortality 3 or more of pyrexia, hypothermia, disorientation, leucopenia, thrombocytopenia, tachypnoea, tachycardia. Vural et al [31] No clinical aims stated Length of stay n/a Burn deaths correlated with bacterial density on biopsy: 5/21 patients died.
All 5 had counts >1x10 5 bacteria/g. 5/16 had counts <1x10 5 and survived.
(-) Results are incomplete -only 10/21 patients accounted for (-) Correlation is claimed, but no statistical tests have been performed (-) Small sample size
Biopsies have a diagnostic value for monitoring wound infection. Patients with burn wounds which showed >10 5 orgs/gram more likely to die even with additional measures, though this number was too small to reach statistical significance. Loebl et al [10] Surface cultures (not swabs) and biopsies (210; >20%)
Positive biopsies defined as QM counts of ≥10
